Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360812338> ?p ?o ?g. }
- W4360812338 endingPage "27" @default.
- W4360812338 startingPage "19" @default.
- W4360812338 abstract "This study aimed to evaluate the efficacy and safety of vonoprazan (VPZ) versus proton pump inhibitor (PPI) in clarithromycin-based bismuth-containing quadruple therapy (C-BQT) for the treatment of Helicobacter pylori (H. pylori) eradication.Medical records of patients in whom H. pylori was eradicated between 1 July 2018 and 31 December 2021 were retrieved retrospectively from the Outpatient Unit of Qilu Hospital. Efficacy, safety, and compliance were compared between VPZ-based and PPI-based C-BQT, containing vonoprazan 20 mg or proton pump inhibitors (lansoprazole 30 mg or esomeprazole 20 mg), bismuth 220 or 200 mg, amoxicillin 1000 mg, and clarithromycin 500 mg, twice daily for 2 weeks by 1:1 propensity score matching analysis. The trial was registed on ClinicalTrials.gov (registration no. NCT05301725).The H. pylori eradication rates of VPZ-based and PPI-based therapies were 88.8% (151/170) and 87.6% (149/170) in the intention-to-treat analysis, 94.1% (144/153) and 91.1% (144/158) in the per-protocol analysis, respectively. The noninferiority of VPZ to PPI was confirmed in all analyses (P < 0.001). The incidence of adverse events was 30.0% (51/170) and 27.1% (46/170) in the VPZ-based and PPI-based groups, respectively. VPZ-based and PPI-based therapies were well tolerated and showed good patient compliance without significant differences.VPZ-based therapy resulted in a satisfactory eradication rate and was well tolerated for H. pylori eradication, which are comparable to PPIs in C-BQT as a first-line treatment for H. pylori infection." @default.
- W4360812338 created "2023-03-25" @default.
- W4360812338 creator A5006689949 @default.
- W4360812338 creator A5011016505 @default.
- W4360812338 creator A5012448384 @default.
- W4360812338 creator A5017626260 @default.
- W4360812338 creator A5018892762 @default.
- W4360812338 creator A5023259701 @default.
- W4360812338 creator A5024753918 @default.
- W4360812338 creator A5029686897 @default.
- W4360812338 creator A5035282947 @default.
- W4360812338 creator A5037253664 @default.
- W4360812338 creator A5051465534 @default.
- W4360812338 creator A5052967704 @default.
- W4360812338 creator A5058221902 @default.
- W4360812338 creator A5075077562 @default.
- W4360812338 creator A5088527557 @default.
- W4360812338 date "2023-01-01" @default.
- W4360812338 modified "2023-10-11" @default.
- W4360812338 title "Vonoprazan is noninferior to proton pump inhibitors in bismuth‐containing quadruple therapy for the treatment of <i>Helicobacter pylori</i> infection: A propensity score matching analysis" @default.
- W4360812338 cites W1537289008 @default.
- W4360812338 cites W1826619807 @default.
- W4360812338 cites W1883517927 @default.
- W4360812338 cites W2045383793 @default.
- W4360812338 cites W2064401560 @default.
- W4360812338 cites W2072080364 @default.
- W4360812338 cites W2078125568 @default.
- W4360812338 cites W2078951211 @default.
- W4360812338 cites W2139464969 @default.
- W4360812338 cites W2172306046 @default.
- W4360812338 cites W2263960908 @default.
- W4360812338 cites W2289768434 @default.
- W4360812338 cites W2333829219 @default.
- W4360812338 cites W2336356383 @default.
- W4360812338 cites W2407944033 @default.
- W4360812338 cites W2531963478 @default.
- W4360812338 cites W2543543112 @default.
- W4360812338 cites W2570938003 @default.
- W4360812338 cites W2597296890 @default.
- W4360812338 cites W2613485273 @default.
- W4360812338 cites W2753033207 @default.
- W4360812338 cites W2790522681 @default.
- W4360812338 cites W2792934812 @default.
- W4360812338 cites W2793210971 @default.
- W4360812338 cites W2806961124 @default.
- W4360812338 cites W2888976927 @default.
- W4360812338 cites W2889945078 @default.
- W4360812338 cites W2913380227 @default.
- W4360812338 cites W2916696793 @default.
- W4360812338 cites W2975288503 @default.
- W4360812338 cites W2999210040 @default.
- W4360812338 cites W3133926799 @default.
- W4360812338 cites W3165355806 @default.
- W4360812338 cites W3169805734 @default.
- W4360812338 cites W4220795006 @default.
- W4360812338 cites W4220940410 @default.
- W4360812338 doi "https://doi.org/10.1111/1751-2980.13166" @default.
- W4360812338 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36960538" @default.
- W4360812338 hasPublicationYear "2023" @default.
- W4360812338 type Work @default.
- W4360812338 citedByCount "0" @default.
- W4360812338 crossrefType "journal-article" @default.
- W4360812338 hasAuthorship W4360812338A5006689949 @default.
- W4360812338 hasAuthorship W4360812338A5011016505 @default.
- W4360812338 hasAuthorship W4360812338A5012448384 @default.
- W4360812338 hasAuthorship W4360812338A5017626260 @default.
- W4360812338 hasAuthorship W4360812338A5018892762 @default.
- W4360812338 hasAuthorship W4360812338A5023259701 @default.
- W4360812338 hasAuthorship W4360812338A5024753918 @default.
- W4360812338 hasAuthorship W4360812338A5029686897 @default.
- W4360812338 hasAuthorship W4360812338A5035282947 @default.
- W4360812338 hasAuthorship W4360812338A5037253664 @default.
- W4360812338 hasAuthorship W4360812338A5051465534 @default.
- W4360812338 hasAuthorship W4360812338A5052967704 @default.
- W4360812338 hasAuthorship W4360812338A5058221902 @default.
- W4360812338 hasAuthorship W4360812338A5075077562 @default.
- W4360812338 hasAuthorship W4360812338A5088527557 @default.
- W4360812338 hasConcept C126322002 @default.
- W4360812338 hasConcept C17923572 @default.
- W4360812338 hasConcept C197934379 @default.
- W4360812338 hasConcept C2776409635 @default.
- W4360812338 hasConcept C2776962512 @default.
- W4360812338 hasConcept C2778204628 @default.
- W4360812338 hasConcept C2778715759 @default.
- W4360812338 hasConcept C2779708577 @default.
- W4360812338 hasConcept C2781025758 @default.
- W4360812338 hasConcept C501593827 @default.
- W4360812338 hasConcept C71924100 @default.
- W4360812338 hasConcept C86803240 @default.
- W4360812338 hasConcept C89423630 @default.
- W4360812338 hasConcept C90924648 @default.
- W4360812338 hasConceptScore W4360812338C126322002 @default.
- W4360812338 hasConceptScore W4360812338C17923572 @default.
- W4360812338 hasConceptScore W4360812338C197934379 @default.
- W4360812338 hasConceptScore W4360812338C2776409635 @default.
- W4360812338 hasConceptScore W4360812338C2776962512 @default.
- W4360812338 hasConceptScore W4360812338C2778204628 @default.
- W4360812338 hasConceptScore W4360812338C2778715759 @default.